IACTA APAC

Up-to-date

News

News2021-01-07T22:35:17+00:00

FEATURED STORY

IACTA Pharmaceuticals and Pharmaleads to Develop the World’s First Epithelial Protective Drug Harnessing Endogenous Analgesia for the Topical Treatment of Acute and Chronic Ocular Pain

Ocular pain is a $10+ billion global market with significant unmet medical need. IACTA and Pharmaleads are teaming up to accelerate global development of DENKIs, leveraging expertise and resources of both companies.

Read more

Contact us

tel: (844) IACTA RX
email: db@iactapharma.com

All news

Go to Top